Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Gian Luca Erre MD, PhD, Arduino Aleksander Mangoni MD

Abstract

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

Article Details

Article Type

Editorial

DOI

10.7573/dic.2020-12-1

Publication Dates

Accepted: ; Published: .

Citation

Erre GL, Mangoni AA. Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue. Drugs in Context 2021; 10: 2020-12-1. DOI: 10.7573/dic.2020-12-1

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.